USA -
engelsk -
NLM (National Library of Medicine)
impavido- miltefosine capsule
profounda, inc. - miltefosine (unii: 53ey29w7ec) (miltefosine - unii:53ey29w7ec) - miltefosine 50 mg - impavido (miltefosine) capsules are indicated in adults and pediatric patients 12 years of age and older weighing greater than or equal to 30 kg (66 lbs) for the treatment of: limitations of use: impavido is contraindicated in patients who are pregnant. based on animal data, miltefosine may cause fetal harm. [see boxed warning, warnings and precautions (5.1) and use in specific populations (8.1)]. impavido is contraindicated in patients who have sjögren-larsson-syndrome [see clinical pharmacology (12.3)] . impavido is contraindicated in patients who are hypersensitive to miltefosine or any impavido excipients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to impavido during pregnancy. healthcare providers are encouraged to register patients by calling 1-866-588-5405. risk summary impavido is contraindicated during pregnancy. based on data from animal reproduction studies, impavido may cause embryo-fetal toxicity when administered to pre
USA -
engelsk -
NLM (National Library of Medicine)
impavido miltefosine capsule
paladin therapeutics inc. - miltefosine (unii: 53ey29w7ec) (miltefosine - unii:53ey29w7ec) - miltefosine 50 mg
Israel -
engelsk -
Ministry of Health
impavido 10 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
Israel -
engelsk -
Ministry of Health
impavido 50 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
Frankrike -
fransk -
ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
miltex 6 pour cent (0,6 g/10 ml), solution pour application cutanée en flacon
baxter sas - miltéfosine - solution - 6 g - composition pour 100 ml > miltéfosine : 6 g - cytostatique.
Nederland -
nederlandsk -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
milteforan 20 mg/ml orale oplossing voor honden
virbac - miltefosine - vloeistof voor oraal gebruik - miltefosine 20 mg/ml - agents against leishmaniosis and trypanosomosis - optional class. - honden
Israel -
hebraisk -
Ministry of Health
אימפבידו 10 מג
megapharm ltd - miltefosine - קפסולה קשיחה - miltefosine 10 mg - miltefosine
Israel -
hebraisk -
Ministry of Health
אימפבידו 10 מג
megapharm ltd - miltefosine - קפסולה קשיחה - miltefosine 10 mg - miltefosine
Israel -
hebraisk -
Ministry of Health
אימפבידו 50 מג
megapharm ltd - miltefosine - קפסולה קשיחה - miltefosine 50 mg - miltefosine
Israel -
hebraisk -
Ministry of Health
אימפבידו 50 מג
megapharm ltd - miltefosine - קפסולה קשיחה - miltefosine 50 mg - miltefosine